📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Peripheral Neuropathy Companies

Peripheral neuropathy refers to damage to the peripheral nerves, resulting in symptoms such as pain, tingling, numbness, and weakness, often in the hands and feet. Several companies are involved in the development of treatments, therapies, and diagnostic tools for peripheral neuropathy.

Peripheral Neuropathy Key CompaniesLatest Peripheral Neuropathy Treatment Companies Update

April 2023: Neuspera® Medical, a medical device business focused on the development of implanted devices for individuals with chronic conditions, has recently disclosed the attainment of approval from the U.S. Food and Drug Administration (FDA) for the advanced Neuspera ultra-miniaturized system. The system consists of a micro-implant that administers neurostimulation treatment via a wireless platform, which includes a wearable transmitter and an iPad-based clinician programmer.  The Neuspera system offers a wireless and adaptable platform for delivering peripheral nerve stimulation (PNS), which is less invasive compared to existing commercially available technologies. This PNS device represents a significant advancement as it introduces an ultra-miniaturized alternative, potentially enhancing the patient's experience and providing increased procedural adaptability. The device in question is approximately 75 times smaller than the smallest implanted pulse generator now available in the commercial market.

January 2023: NeuroMetrix, a prominent manufacturer of medical devices, commenced the release of DPNCheck 2.0. The focal point of the DPNCheck system revolves around a portable device that is outfitted with biosensors. These biosensors are utilized to detect indications of peripheral neuropathy, a prevalent medical condition characterized by nerve impairment. The resulting symptoms of this condition are typically localized in the extremities, specifically the hands and feet, and encompass weakness, numbness, pain, and a tingling sensation. The functionality of the device is based on the assessment of nerve conduction velocity and response amplitude in the sural nerve located in the lower leg. These specific variables have been recognized as reliable biomarkers for the disease.List of Peripheral Neuropathy Treatment Key companies in the market

  • Abbott Laboratories (US)

  • Bristol Myers Squibb (US)

  • Novartis AG (UK)

  • Eli Lilly and Company (US)

  • Pfizer Inc. (US)

  • GlaxoSmithKline plc (UK)

  • Merck and Co. Inc. (US)

  • Cipla Limited (India)

  • Lupin Limited (India)

  • Reddy's Laboratories (India)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.